Close Menu

NEW YORK (GenomeWeb) – A panel of 19 microRNAs can distinguish malignant and benign thyroid nodules, which may help identify patients who would benefit from treatment.

While most thyroid nodules are benign, about 7 percent are malignant. Currently, suspicious thyroid nodules are evaluated by ultrasound-guided fine-needle aspiration biopsy and while that can settle some of the cases, about 30 percent of patients receive ambiguous results.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Sponsored by

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Sponsored by

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.